Cargando…

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Understanding the source of viral persistence is essential for developing strategies to eradicate HIV-1 infection. We therefore investigated the level of plasma HIV-1 RNA in patients with viremia suppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maldarelli, Frank, Palmer, Sarah, King, Martin S, Wiegand, Ann, Polis, Michael A, Mican, JoAnn, Kovacs, Joseph A, Davey, Richard T, Rock-Kress, Diane, Dewar, Robin, Liu, Shuying, Metcalf, Julia A, Rehm, Catherine, Brun, Scott C, Hanna, George J, Kempf, Dale J, Coffin, John M, Mellors, John W
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847689/ https://www.ncbi.nlm.nih.gov/pubmed/17411338 http://dx.doi.org/10.1371/journal.ppat.0030046

Ejemplares similares

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors
por: Kurian, Jujju Jacob, et al.
Publicado: (2018)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2011)

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
por: Archin, Nancie M., et al.
Publicado: (2010)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
por: Shi, Cong, et al.
Publicado: (2022)

Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation
por: Swaminathan, Sanjay, et al.
Publicado: (2016)

Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
por: Kearney, Mary F., et al.
Publicado: (2014)

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)

Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection
por: Kearney, Mary F., et al.
Publicado: (2012)

Metastatic HPV‐related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment
por: Perri, Francesco, et al.
Publicado: (2017)

Investigation of the Suitability of a Commercial Radiation Sensor for Pretherapy Dosimetry of Radioiodine Treatment Patients
por: O’Callaghan, Janet, et al.
Publicado: (2022)

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
por: Voorhees, Timothy J., et al.
Publicado: (2022)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA
por: Boltz, Valerie F., et al.
Publicado: (2016)

Retrovirus Integration Database (RID): a public database for retroviral insertion sites into host genomes
por: Shao, Wei, et al.
Publicado: (2016)

Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults
por: Kearney, Mary F., et al.
Publicado: (2018)

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer
por: Shi, Hui, et al.
Publicado: (2018)

Mortality among Cancer Patients within 90 Days of Therapy in a Tertiary Hospital, Tanzania: Is Our Pretherapy Screening Effective?
por: Changalucha, Marygoreth J., et al.
Publicado: (2020)

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
por: Cillo, Anthony R., et al.
Publicado: (2014)

Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
por: Wu, Jianxiong, et al.
Publicado: (2012)

Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents
por: Mills, Anthony M, et al.
Publicado: (2021)

Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung
por: Chen, Zhiyong, et al.
Publicado: (2022)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Nonsuppressible viremia during HIV-1 therapy meets molecular virology
por: Emery, Ann, et al.
Publicado: (2023)

Pretherapy (18)F-FDG PET/CT in Predicting Disease Relapse in Patients With Immunoglobulin G4-Related Disease: A Prospective Study
por: Cheng, Mei-Fang, et al.
Publicado: (2023)

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
por: Musick, Andrew, et al.
Publicado: (2019)

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
por: Shao, Wei, et al.
Publicado: (2009)

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir
por: Bui, John K., et al.
Publicado: (2017)

Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA
por: Shao, Wei, et al.
Publicado: (2013)

Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4(+) T-cells Contain One HIV-1 DNA Molecule
por: Josefsson, Lina, et al.
Publicado: (2013)

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
por: Meyer, Manuela F, et al.
Publicado: (2007)

VIREMIA IN HUMAN POLIOMYELITIS
por: Horstmann, Dorothy M., et al.
Publicado: (1954)

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017)

Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
por: Kassaye, Seble G., et al.
Publicado: (2019)

B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells
por: Moir, Susan, et al.
Publicado: (2000)

A Clinical Trial of Optimal Time Interval Between Ablation and Diagnostic Activity When a Pretherapy RAI Scanning Is Performed on Patients With Differentiated Thyroid Carcinoma
por: Yin, Yafu, et al.
Publicado: (2015)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
por: Tosiano, Melissa A., et al.
Publicado: (2022)

Rotavirus Antigenemia in Children Is Associated with Viremia
por: Blutt, Sarah E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_fq50aesbia1r11423c0gafgt61